After completing his residency in 2013, Dr. Massumi began a fellowship program in cardiovascular diseases at the Texas Heart Institute at Baylor St. Luke’s Medical Center, which he completed in 2016. He followed with a dedicated advanced fellowship in interventional cardiology at the Texas Heart Institute, which he completed in 2017. Between 2008 and 2017, Dr. Massumi was involved in several research projects, including: to perform BAV (balloon aortic valvuloplasty) or not, that is a TAVR (transcatheter aortic valve replacement) question; effect of botulinum toxin on inducibility and maintenance of atrial fibrillation in ovine myocardial tissue; endovascular treatment of superior vena cava syndrome secondary to pacemaker placement using balloon in balloon venoplasty and palmaz stent; prediction of imminent endocardial perforation via specific alterations of measurable and calculable variables at the catheter tip/endocardial interface; and the outcome of breast reduction surgery on quality of life regardless of amount resected or patient weight.
Dr. Massumi joined Kelsey-Seybold in June 2017, where he previously worked in the Lipid Clinic for a year (in 2004) between completion of his undergraduate degree in biology and the start of medical school, researching patient charts and conducting patient interviews.
Print
Email